Morgan Stanley has increased its investment rating on insurer Marsh & McLennan. From “equal weight” to “overweight.”
An analyst reported that the company’s stock price decline has been overdone given Marsh & McLennan’s variety of earnings mix, which includes profits from its fast-growing insurance brokerage segment.
According to the analyst, MMC is expected to generate $1.3 billion for free cash flow during the year.
Was this article valuable?
Here are more articles you may enjoy.
Trump Administration Backtracks on Removing Ocean Sensors 
Capital Factory CEO Killed in Private-Jet Crash in Texas 
DeSantis Signs Citizens Commercial Clearinghouse Bill That’s Been Called ‘Unneeded’ 
Zurich Sees Data Center Boom Spurring Insurance Securitization 
